Navigation Links
Data Presented at ACR Meeting Demonstrate Safety of Colcrys® (Colchicine, USP) for Treatment of Gout Flares in Patients with Multiple Co-Morbid Conditions
Date:11/8/2010

ATLANTA, Nov. 8, 2010 /PRNewswire/ -- Patients who experience gout flares can be treated safely with Colcrys® (colchicine, USP), even in the presence of co-morbid conditions that often present physicians with treatment challenges, according to a new analysis presented here at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR).

"Many patients with gout have other serious health conditions to consider, including cardiovascular and metabolic disorders, hypertension and kidney disease, which can make gout treatment complex," said Matthew W. Davis, M.D., R.Ph., Chief Medical Officer, URL Pharma. "This analysis demonstrates that patients with these comorbidities did not have an increased likelihood of adverse events from the use of Colcrys."

Data were collected as part of a post-hoc analysis of The Acute Gout Flare Receiving Colchicine Evaluation (AGREE) trial, a pivotal Phase 3 study of Colcrys in the treatment of gout flares. AGREE results were presented at the 2009 ACR annual meeting, and were published in Arthritis & Rheumatism in March 2010.

Colcrys is the only single-ingredient colchicine product approved by the U.S. Food and Drug Administration (FDA) for the prevention and treatment of gout flares, and for the treatment of Familial Mediterranean Fever (FMF).

Study Design

This Phase 3, randomized, double-blind, placebo-controlled parallel group study represents a regression analysis of the previously presented AGREE trial. A total of 185 patients meeting ACR criteria for acute gout flares were randomized to receive, within 12 hours of symptom onset, either high-dose colchicine (1.2 mg, then 0.6 mg hourly x 6 hours = 4.8 mg total); Colcrys (1.2 mg, then 0.6 mg in 1 hour = 1.8 mg total, followed by 5 placebo doses hourly); or placebo (2 capsules, then 1 capsule hourly x 6 hours).  

Logistics regression was undertaken using presence or absence of adverse events (AEs
'/>"/>

SOURCE URL Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 The law firm of Rheingold, Valet, Rheingold, ... to be the first suit in New York ... user of two common anti-diabetic drugs, Byetta and Janumet (also ... resident Robert Cataletto , was filed on ... E.D.N.Y. CV 13-3411. Mr. Cataletto received prescriptions from ...
(Date:6/17/2013)... June 17, 2013   Southern Research Institute ... has been selected by its Board of Directors to ... July 8, 2013.   (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ... Secrist, III, Ph.D., who served as president and CEO ... his retirement earlier this year after 34 years of ...
(Date:6/17/2013)... AVIV, Israel , June 17, 2013 ... the Board of Governors of the Israel-U.S. Binational Industrial ... million in funding for fourteen new projects between Israeli ... BIRD , the projects will access private sector ... approximately $33 million. The semi-annual meeting was held at ...
Breaking Medicine Technology:Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4
... 2011 Time is money, and time that is wasted looking ... A first-of-its-kind mobile and HTML5 app released by Providian Medical ... both time and money. With just a few quick and easy ... the optimum ultrasound machines based on their individual needs. The app ...
... SuccessEHS will sponsor the California Primary Care Association (CPCA) ... statewide leader and recognized voice representing the interests of ... CPCA represents more than 800 not-for-profit community clinics and ... SuccessEHS supports CPCA,s mission of eliminating ...
Cached Medicine Technology:Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever 2SuccessEHS Sponsors California Primary Care Association 2SuccessEHS Sponsors California Primary Care Association 3
(Date:6/17/2013)... social media push boosted the number of people who ... day, Johns Hopkins researchers found, suggesting social media might ... shortage in the United States. , The gains were ... created a way for users to share their organ ... make their status official on state department of motor ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
(Date:6/17/2013)... men with low-risk, localized prostate cancers can safely ... undergoing immediate treatment and have better quality of ... a study by researchers at Dana-Farber Cancer Institute ... June 18 issue of the Annals of ... models showed that "observation is a reasonable and, ...
(Date:6/17/2013)... Vegas Hotel Escapes, the top Las Vegas ... Berlin at the Lavo. Those traveling to Las Vegas to ... affordable rates we are offering. , VegasHotelEscapes is pleased ... hotels in Las Vegas on the strip , such as ... VegasHotelEscapes.com is pleased to offer the absolute lowest prices possible ...
(Date:6/17/2013)... Harvard Stem Cell Institute (HSCI) researchers have identified in ... to regulate embryonic stem cell self-renewal, beginning a creative ... , The gene, SALL4, gives stem cells their ability ... mature cells. Typically, cells only express SALL4 during embryonic ... cases of acute myeloid leukemia and 10 to 30 ...
Breaking Medicine News(10 mins):Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4Health News:Observation is safe, cost-saving in low-risk prostate cancer 2Health News:Observation is safe, cost-saving in low-risk prostate cancer 3Health News:A new target for cancer drug development 2
... the Sally Clark case could lead to a halving in the ... legacy emerging from tragedy, says a feature in this weeks BMJ. ... of her two infant sons. She was imprisoned but won her ... of the case, says Jonathan Gornall, have been devastating for her ...
... investigated and debated for its impact on health conditions ... effects on the body, coffee or its components ... levels on a short-term basis or cross-sectionally. These and ... risk of gout, the most prevalent inflammatory arthritis in ...
... over the past 40 years in England, owing to changes ... finds research published ahead of print in the British Journal ... geographical variation in rates suggest that the NHS is now ... training, say the authors. ,The research team analysed ...
... BMA says it is extremely concerned at the growing interest of ... the belief that these can be non lethal. ,The ... Science, concludes that it is impossible to deliver the right drug ... that is both effective and does not cause significant deaths. The ...
... an average of four to seven glasses of red wine ... with prostate cancer as those who do not drink ... Health Watch. In addition, red wine appears particularly protective against ... information about many factors that might influence the risk of ...
... A decade-long study by neurologists at the University of ... found a link between the increasingly popular weight-loss ... conditions. ,Katalin Juhasz Pocsine, M.D., associate ... author of the study. The study concludes that patients ...
Cached Medicine News:Health News:New Reforms Could Cut the Number of Unexplained Infant Deaths 2Health News:Four Cups of Coffee a Day may Cut Down the Risk of Gout 2Health News:Four Cups of Coffee a Day may Cut Down the Risk of Gout 3Health News:NHS Oversupplied With Cataract Surgery, Say Doctors 2Health News:Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors 2Health News:Link Between Gastric Bypass Surgery and Neurological Conditions 2
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... Innova 2100IQ: See the finest vessels from ... devices. Its all enabled by the Revolution ... deliver excellent image quality and dose efficiency. ... installed worldwide, more physicians rely on these ...
... as Antidiurectic Hormone (ADH), is synthesized in ... flow to the posterior pituitary for storage ... by changes in blood osmolality and also ... blood volume or arterial pressure. Non-osmotic stimuli ...
Medicine Products: